Management of Papanicolaou test results that lack endocervical cells

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 5, 2011, Pages 563-568

  Elumir Tanner, Lizette ^a   Doraty, Meghan ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; CASE CONTROL STUDY; CELL; CELL COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; CYTOLOGY; ENDOCERVICAL CELL; HUMAN; PAPANICOLAOU TEST; PRACTICE GUIDELINE; REVIEW; SAMPLING; UTERINE CERVIX CARCINOMA;

EID: 79952847893     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.101156     Document Type: Review

References (39)

1. Liu S, Semenciw R, Probert A, et al. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001;11:24-31. (Pubitemid 32218712)
2. Apgar BS, Zoschnick L, Wright TC. The 2001 Bethesda System terminology. Am Fam Physician 2003;68:1992-8.
3. The periodic health examination. Canadian Task Force on the Periodic Health Examination. CMAJ 1979;121:1193-254.
4. Weinstein LC, Buchanan EM, Hillson C, et al. Screening and prevention: cervical cancer. Prim Care 2009;36:559-74.
5. Elias A, Linthorst G, Bekker B, et al. The significance of endocervical cells in the diagnosis of cervical epithelial changes. Acta Cytol 1983;27:225-9. (Pubitemid 13071767)
6. Kivlahan C, Ingram E. Papanicolaou smears without endocervical cells: Are they inadequate? Acta Cytol 1986;30:258-60.
7. Vooijs PG, Elias A, van der Graaf Y, et al. Relationship between the diagnosis of epithelial abnormalities and the composition of cervical smears. Acta Cytol 1985;29:323-8. (Pubitemid 15044820)
8. Kristensen GB, Skyggebjerg KD, Hølund B, et al. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. Acta Cytol 1991;35:47-50.
9. Laverty CR, Farnsworth A, Thurloe JK, et al. The importance of the cell sample in cervical cytology: a controlled trial of a new sampling device. Med J Aust 1989;150:432-4, 436.
10. Mauney M, Eide D, Sotham J. Rates of condyloma and dysplasia in papanicolaou smears with and without endocervical cells. Diagn Cytopathol 1990;6:18-21.
11. Woodman CB, Williams D, Yates M, et al. Indicators of effective cytological sampling of the uterine cervix. Lancet 1989;2:88-90. (Pubitemid 19173306)
12. Beeby AR, Wadehra V, Keating PJ, et al. A retrospective analysis of 94 patients with CIN and false negative cervical smears taken at colposcopy. Cytopathology 1993;4:331-7. (Pubitemid 24007941)
13. Robertson JH, Woodend B. Negative cytology preceding cervical cancer: causes and prevention. J Clin Pathol 1993;46:700-2. (Pubitemid 23242417)
14. Ribeiro AA, Santos Sdo C, de Souza e Silva SR, et al. Endocervical component in conventional cervical smears: influence on detection of squamous cytologic abnormalities. Diagn Cytopathol 2007;35:209-12.
15. Kwikkel HJ, Quaak MJ, de With C. Predictive value of the abnormal PAP smear: a retrospective analysis of error rates. Eur J Obstet Gynecol Reprod Biol 1986;21:101-12. (Pubitemid 16177493)
16. Mitchell H, Medley G. Longitudinal study of women with negative cervical smears according to endocervical status. Lancet 1991;337:265-7.
17. Mitchell H, Medley G. Influence of endocervical status on the cytologic prediction of cervical intraepithelial neoplasia. Acta Cytol 1992;36:875-80.
18. Mitchell H, Medley G. Cytological reporting of cervical abnormalities according to endocervical status. Br J Cancer 1993;67:585-8. (Pubitemid 23077657)
19. Sidawy MK, Tabbara SO, Silverberg SG. Should we report cervical smears lacking endocervical component as unsatisfactory? Diagn Cytopathol 1992;8:567-70.
20. O'Sullivan JP, A'Hern RP, Chapman PA, et al. A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia. Cytopathology 1998;9:155-61. (Pubitemid 28277261)
21. Bos AB, van Ballegooijen M, Elske van den Akker-van Marle M, et al. Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears. Am J Clin Pathol 2001;115:851-5. (Pubitemid 32476711)
22. Mitchell HS. Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status. Cancer 2001;93:237-40. (Pubitemid 32777528)
23. Selvaggi SM, Guidos BJ. Endocervical component: Is it a determinant of specimen adequacy? Diagn Cytopathol 2002;26:53-5.
24. Siebers AG, de Leew H, Verbeek AL, et al. Prevalence of squamous abnormalities in women with a recent smear without endocervical cells is lower as compared to women with smears with endocervical cells. Cytopathology 2003;14:58-65. (Pubitemid 36577958)
25. Pajtler M, Audy-Jurković S. Pap smear adequacy - is the assessing criterion including endocervical cells really valid? Coll Antropol 2002;26:565-70.
26. Tacken MA, Braspenning JC, Mulder J, et al. Loss to follow-up of cervical smears without endocervical columnar cells is not disturbing. Eur J Gynaecol Oncol 2006;27:42-6.
27. Giorgi Rossi P, Baiocchi D, Ciatto S. Endocervical cell Italian working group of cervical cancer screening group. Acta Cytol 2010;54:265-71.
28. Mintzer M, Curtis P, Resnick JC, et al. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer cytopathology. 1999;87:113-7. (Pubitemid 29289244)
29. Guideline for screening for cervical cancer. Edmonton (AB): Toward Optimal Practice Program; 2000. Available: www.topalbertadoctors.org/informed- practice/clinical-practice -guidelines/complete %20set /Cervical%20Cancer /cervical -cancer -guideline.pdf (accessed 2010 July 14)
30. Screening for cancer of the cervix: an office manual for health professionals. Vancouver (BC): Cervical Cancer Screening Program, BC Cancer Agency; 2010. Available: www.bccancer.bc.ca/NR/rdonlyres/BB10EE87-95AB-43F5- 994C-7D8DBD969424/47976/CCSPOfficeManualWebFinal2011.pdf (accessed 2011 Feb. 22).
31. Ontario cervical cancer screening practice guidelines. Toronto (ON): Ontario Cervical Screening Program, Cancer Care Ontario; 2007. Available: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13104 (accessed 2010 July 14).
32. Pap test results in Pap test learning module for health care providers. Winnipeg (MB): Manitoba Cervical Cancer Screening Program, Cancer Care Manitoba; 2009. Available: www.cancercare.mb.ca/resource/File/MCCSP/ HealthCareProfessional/PTLM-Chapter-10.pdf (accessed 2010 July 14).
33. Cervical Screening Initiatives Program 2008: clinical management guidelines. Stephenville (NL): Western Health; 2008. Available: http://westernhealth.nl.ca/uploads/PDFs/Clinical-Mgt-Guidelines-2008.pdf (accessed 2010 July 14).
34. Screening for cancer of the cervix: an office manual for health professionals. Halifax (NS): Cervical Cancer Prevention Program, Cancer Care Nova Scotia; 2009. Available: www.cancercare.ns.ca/site-cc/media/cancercare/ CCPPManual09WEB.pdf (accessed 2010 July 14).
35. Steban M. Clinical manifestation and diagnosis of HPV-related disease In: Canadian consensus guidelines on human papillomavirus. J Obstet Gynaecol Can 2007;29(Suppl 3):S11-4.
36. Cervical Screening Wales quality manual. Section 2 - core reference section. National Health Service London (UK): 2009. Available: www.screeningservices.org.uk/csw/prof/quality/core-reference -v1.0-rev3.pdf (accessed 2010 July 15).
37. Screening to prevent cervical cancer: guidelines for the management of asymptomatic women with screen detected abnormalities. Canberra (Australia): National Health and Medical Research Council; 2006. Available: www.nhmrc.gov.au/-files-nhmrc/file/publications/synopses/wh39.pdf
38. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62. (Pubitemid 35446606)
39. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207-8.